GENEVA, Jan. 4 -- BEIJING INSTITUTE FOR CANCER RESEARCH (No.52 Fu-Cheng RoadHaidian District, Beijing 100142), 北京市肿瘤防治研究所 (中国北京市海淀区阜成路52号) filed a patent application (PCT/CN2025/103534) for "HUMANIZED ANTI-ALPHA-2-DELTA-1 MONOCLONAL ANTIBODY AND APPLICATION THEREOF" on Jun 25, 2025. With publication no. WO/2026/002062, the details related to the patent application was published on Jan 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHAN...